Heparin-binding capacity of the HIV-1 NEF-protein allows one-step purification and biochemical characterization

J Virol Methods. 1996 Jun;60(1):89-101. doi: 10.1016/0166-0934(96)02049-6.

Abstract

Recombinant Nef-protein of HIV-1 Bru derived from Escherichia coli revealed heparin-binding activity. This property was used to purify the Nef-protein by a one-step procedure, yielding about 90% homogenous Nef-protein as evaluated by silver staining. The Nef-protein was soluble without denaturing agents. Native folding of Nef was demonstrated with antibodies against conformational epitopes of Nef by a slot blot assay under native conditions. Despite its affinity to heparin and its nuclear localization in persistently HIV-1 infected glioblastoma cells (Kohleisen et al., 1992), Nef did not show DNA-binding properties by slot blot/hybridization assay and South/Western blot. In nucleotide-binding assays a strong autophosphorylation activity with [gamma-32P]ATP was observed. Nef-protein was not a substrate for ADP-ribosylation by bacterial toxins arguing against G-protein-like activities of Nef. Recombinant Nef did not interact with membranes as shown by the lack of increased fluorescence emission of Nef in the presence of liposomes. The recombinant Nef-protein obtained by one-step heparin-based purification shares immunological properties with native Nef and should prove useful for further studies of Nef function and immunogenicity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Monoclonal / immunology
  • Cell Membrane / metabolism
  • DNA / metabolism
  • Gene Products, nef / genetics
  • Gene Products, nef / isolation & purification
  • Gene Products, nef / metabolism*
  • HIV Antibodies / immunology
  • HIV-1 / metabolism*
  • Heparin / metabolism*
  • Humans
  • Mice
  • Rabbits
  • Recombinant Fusion Proteins / genetics
  • Recombinant Fusion Proteins / isolation & purification
  • Recombinant Fusion Proteins / metabolism
  • Tumor Cells, Cultured
  • nef Gene Products, Human Immunodeficiency Virus

Substances

  • Antibodies, Monoclonal
  • Gene Products, nef
  • HIV Antibodies
  • Recombinant Fusion Proteins
  • nef Gene Products, Human Immunodeficiency Virus
  • Heparin
  • DNA